MedPath
FDA Approval

Terconazole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 31, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terconazole(4 mg in 1 g)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

A-S Medication Solutions

A-S Medication Solutions

830016429

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terconazole

Product Details

NDC Product Code
50090-6266
Application Number
ANDA076712
Marketing Category
ANDA (C73584)
Route of Administration
VAGINAL
Effective Date
March 9, 2021
Code: 0KJ2VE664UClass: ACTIBQuantity: 4 mg in 1 g
BUTYLATED HYDROXYANISOLEInactive
Code: REK4960K2UClass: IACT
CETYL ALCOHOLInactive
Code: 936JST6JCNClass: IACT
ISOPROPYL MYRISTATEInactive
Code: 0RE8K4LNJSClass: IACT
POLYSORBATE 60Inactive
Code: CAL22UVI4MClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
STEARYL ALCOHOLInactive
Code: 2KR89I4H1YClass: IACT
© Copyright 2025. All Rights Reserved by MedPath